Top 20 Biopharmaceutical Company Utilizes Veeva Development Cloud to Accelerate Drug Development Process
Boehringer Ingelheim, a leading biopharmaceutical company, has partnered with Veeva Systems to launch the innovative One Medicine platform. This collaboration aims to streamline clinical, regulatory, and quality processes, ultimately speeding up the development and approval of new medications for currently incurable diseases.
The One Medicine platform, powered by Veeva Development Cloud, enables Boehringer to seamlessly connect data across different functions, optimize trial efficiency, and enhance collaboration with research sites. This cutting-edge technology allows Boehringer to fulfill its commitment to delivering life-changing treatments to patients worldwide in a more efficient and compliant manner.
According to Oliver Fink, Boehringer Ingelheim’s expert in learning, processes, and digitization, Veeva Development Cloud provides the necessary flexibility for designing and conducting studies with speed, efficiency, and compliance. This technology serves as the foundation for the One Medicine platform, empowering Boehringer’s teams to conduct trials more effectively.
Rik van Mol, Veeva Development Cloud’s Senior Vice President, emphasized the importance of connecting clinical, regulatory, and quality services to accelerate drug development. By breaking down data silos and unifying processes, Boehringer and Veeva are striving to modernize clinical trials and achieve better outcomes for patients.
Veeva Development Cloud serves as the technological backbone for product development, integrating clinical, quality, regulatory, and safety applications to simplify end-to-end business processes and ensure process excellence.
For more information on Veeva Development Cloud, visit veeva.com/DevelopmentCloud.
About Boehringer Ingelheim:
Boehringer Ingelheim is a biopharmaceutical company dedicated to developing innovative therapies in areas with unmet medical needs. With a focus on sustainability and a long-term perspective, Boehringer’s commitment to building a healthier, more sustainable future is evident in its research and development efforts. To learn more, visit boehringer-ingelheim.com.
About Veeva Systems:
Veeva is a global leader in cloud software for the life sciences industry. With a focus on innovation, product excellence, and customer success, Veeva serves over 1,000 clients ranging from global biopharmaceutical companies to emerging biotechnology firms. As a public benefit corporation, Veeva is dedicated to balancing the interests of all stakeholders for mutual success. Visit veeva.com for more information.
In conclusion, the collaboration between Boehringer Ingelheim and Veeva Systems represents a significant step towards advancing drug development processes and improving patient outcomes. By leveraging cutting-edge technology and data integration, these companies are paving the way for more efficient and effective clinical trials. Explore the possibilities with Veeva Development Cloud and join the journey towards innovative healthcare solutions.
